Mulai
Regeneron Pharmaceuticals, Inc.
Pembelian

New breakout

Oleh Biotechking
Diupdate
Looking at long term trends. Old breakout finished with multi year consolidation. New breakout started with all time high. Will this new breakout hold?

Trade aktif
With the most recent news that trump used regn-cov2, the recent downward pressure will likely end. More trial data before year end. Maybe an emergency use authorization.

q3 earnings and eoy cancer update

Ebola virus infection and is currently under Priority Review by the U.S. Food and Drug Administration (FDA), with a target action date of October 25, 2020.
Trend Analysis
Biotechking

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.